Facundo Pelorosso
- Immunology top 10%
- Mast cells and histamine 3
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 and COVID-19 Research 4
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 5
- Rehabilitation top 10%
-
- Long-Term Effects of COVID-19 3
-
- Nitric Oxide and Endothelin Effects 3
-
- Blood Coagulation and Thrombosis Mechanisms 3
-
- Cardiac Arrhythmias and Treatments 2
- Co-authors
- Rodolfo Pedro RothlinPaula Licona-LimónLidia BosurgiRichard A. FlavellYong KongSourav GhoshYing CaoJoseph Craft
- Journals
- Journal of Pharmacology and Experimental Therapeutics (4 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (4 papers)European Journal of Pharmacology (3 papers)
- Partner nations
- ArgentinaUnited StatesSingapore
In The Last Decade
Facundo Pelorosso
21 papers receiving 872 citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Immunology 321
- Infectious Diseases 173
- Genetics 68
- Rehabilitation 39
- Neurology 69
Countries citing papers authored by Facundo Pelorosso
This map shows the geographic impact of Facundo Pelorosso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Facundo Pelorosso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Facundo Pelorosso more than expected).
Fields of papers citing papers by Facundo Pelorosso
This network shows the impact of papers produced by Facundo Pelorosso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Facundo Pelorosso. The network helps show where Facundo Pelorosso may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Facundo Pelorosso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2021 | 98 | |
| 3 | 2021 | 21 | |
| 4 | 2020 | 64 | |
| 5 | 2018 | 1 | |
| 6 | Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cellsbreakdown → | 2017 | 401 |
| 7 | 2016 | 2 | |
| 8 | 2016 | 20 | |
| 9 | 2011 | 35 | |
| 10 | 2009 | 99 | |
| 11 | 2009 | 8 | |
| 12 | 2008 | 2 | |
| 13 | 2007 | 8 | |
| 14 | 2007 | 6 | |
| 15 | 2006 | 4 | |
| 16 | 2006 | 13 | |
| 17 | 2005 | 14 | |
| 18 | 2002 | 10 | |
| 19 | 2002 | 10 | |
| 20 | 1999 | 26 |
About Facundo Pelorosso
Facundo Pelorosso is a scholar working on Genetics, Infectious Diseases and Hematology, having authored 22 papers that have together received 876 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Mast cells and histamine (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Long-Term Effects of COVID-19 (3 papers) and Cardiac Arrhythmias and Treatments (2 papers). The work is most often cited by research in Immunology (321 citations), Infectious Diseases (173 citations) and Genetics (68 citations). Facundo Pelorosso has collaborated with scholars based in Argentina, United States and Singapore. Frequent co-authors include Rodolfo Pedro Rothlin, Paula Licona-Limón, Lidia Bosurgi, Richard A. Flavell, Yong Kong, Sourav Ghosh, Ying Cao, Joseph Craft, Mar Cabeza-Cabrerizo and Jason S. Weinstein. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Naunyn-Schmiedeberg s Archives of Pharmacology, European Journal of Pharmacology, Proceedings of the National Academy of Sciences and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.